Opioid Use Disorder (OUD) Market Growth Revenue, Statistics, Share And Opportunities 2024-2033

Spread the love

The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033.

The Opioid Use Disorder (OUD) Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Opioid Use Disorder (OUD) Market:

According to The Business Research Company’s Opioid Use Disorder (OUD) Global Market Report 2024, The opioid use disorder (oud) market size has grown rapidly in recent years. It will grow from $3.53 billion in 2023 to $3.93 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%.  The  growth in the historic period can be attributed to increased prescription rates, pain management practices, drug marketing, stigmatization of addiction.The opioid use disorder (oud) market size is expected to see rapid growth in the next few years. It will grow to $6.04 billion in 2028 at a compound annual growth rate (CAGR) of 11.3%.

The increasing prevalence of chronic diseases is expected to drive the growth of the opioid use disorder (OUD) market in the future. Chronic diseases are conditions that persist for a year or longer, requiring ongoing medical attention and often limiting daily activities. Many chronic illnesses, such as cancer, arthritis, or other long-term conditions, are associated with severe pain that may necessitate the use of opioid medications for effective pain management. For example, according to the National Centre for Biotechnology Information (NCBI), it is projected that by 2050, the number of individuals aged 50 years and older with at least one chronic illness will increase by 99.5%, rising from 71.522 million in 2020 to 142.66 million. This rise in chronic disease prevalence underscores the growing demand for treatments, including opioids, to manage associated pain, thus propelling the growth of the opioid use disorder (OUD) market.
Get A Free Sample Of The Report (Includes Graphs And Tables):

The opioid use disorder (oud) market covered in this report is segmented –
1) By Drug Type
: Buprenorphine, Naltrexone, Methadone
2) By Route of Administration: Oral, Parenteral
3) By Age Group: 19 To 40, 41 To 60, 61 And Over
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Top Major Players

Pfizer Inc.,

Novartis AG,

AstraZeneca plc.,

Viatris Inc.,

Teva Pharmaceutical Industries Ltd.

The opioid use disorder (oud) market report table of contents includes:
              1. Executive Summary

  1. Opioid Use Disorder (OUD) Market Characteristics
  2. Opioid Use Disorder (OUD) Market Trends And Strategies
  3. Opioid Use Disorder (OUD) Market – Macro Economic Scenario
  4. Global Opioid Use Disorder (OUD) Market Size and Growth
  5. Opioid Use Disorder (OUD) Market Segmentation
  6. Opioid Use Disorder (OUD) Market Regional And Country Analysis


  1. Key Mergers And Acquisitions In The Opioid Use Disorder (OUD) Market
  2. Opioid Use Disorder (OUD) Market Future Outlook and Potential Analysis
  3. Appendix

List Of Tables :

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Opioid Use Disorder (OUD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Opioid Use Disorder (OUD) Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Opioid Use Disorder (OUD) Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion


Table 75: Pfizer Inc. Financial Performance

Table 76: Novartis AG Financial Performance

Table 77: AstraZeneca plc. Financial Performance

Table 78: Viatris Inc. Financial Performance

Table 79: Teva Pharmaceutical Industries Ltd. Financial Performance                                           

Read Related Reports :



Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Spread the love

About Top PR News

TopPRnews Leads Drives Search Engine Visibility For Your Press Release Content. Our Global Network Reaches Important Contacts, Media Partners And Websites And Journalists. Happy Postings! If You Have Any Queries Please Contact Official Mail At [[email protected]}

View all posts by Top PR News →